Medicines for Europe 3rd Value Added Medicines Conference 2019
Our population is ageing. We are living and working longer, opening the possibilities for specific ‘silver’ needs, namely in healthcare where chronic diseases are becoming more prevalent.
Value added medicines can provide new solutions for patients, healthcare professionals and healthcare systems in this new era by improving patient adherence, quality of life and other health outcomes, as well as by tackling healthcare system inefficiencies, healthcare provision and organisation.
During the conference, you will learn how to create an optimal environment to enable elderly people to benefit from value added medicines and the role of the various healthcare stakeholders in this process.
You will learn more about regulatory and legal topics, market access, the future outlook in the digital space of value added medicines and much more!
- HDAP Meeting / Conference Call
- Nov 25 2019
- All of the day